Analysis of Anti-JCV antibody in Japanese patients with multiple sclerosis

被引：1
|
作者：
Aoyama, S. [1 ]
Mori, M. [2 ]
Uchida, T. [2 ]
Masuda, H. [2 ]
Ohtani, R. [2 ]
Sugimoto, K. [2 ]
Liu, J. [2 ]
Kuwabara, S. [2 ]
机构：
[1] Chiba Univ, Dept Neurol, Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan
[2] Chiba Univ, Dept Neurol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.682
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
654
引用
收藏
页码：238 / 239
页数：2
相关论文
共 50 条
  • [21] Anti-JCV antibody serology is associated with CSF cell counts in multiple sclerosis patients with and without natalizumab treatment
    Schneider-Hohendorf, T.
    Schulte-Mecklenbeck, A.
    Ostkamp, P.
    Luessi, F.
    Klotz, L.
    Zipp, F.
    Wiendl, H.
    Gross, C. C.
    Schwab, N.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1007 - 1007
  • [22] Epidemiology of Anti-JCV Antibodies in Israeli Multiple Sclerosis Population
    Achiron, Anat
    Chapman, Joab
    Dolev, Mark
    Magalashvili, David
    Stern, Yael
    Hillel, Moran
    Kassierer, Tamar
    Raz, Havi
    Gurevich, Michael
    NEUROLOGY, 2012, 78
  • [23] Stability of anti-JCV antibody index in multiple sclerosis: a 6-year longitudinal study
    Hegen, H.
    Auer, M.
    Bsteh, G.
    Di Pauli, F.
    Deisenhammer, F.
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 582 - 582
  • [24] Stability of Anti-JCV Antibody Index in Multiple Sclerosis: A 6-Year Longitudinal Study
    Hegen, Harald
    Auer, Michael
    Bsteh, Gabriel
    Di Pauli, Franziska
    Deisenhammer, Florian
    Berger, Thomas
    NEUROLOGY, 2016, 86
  • [25] Prevalence of anti-JCV antibodies in a multi-national cohort of multiple sclerosis patients
    Olsson, T.
    Achiron, A.
    Alfredsson, L.
    Chan, A.
    Comi, G.
    Hillert, J.
    Moiola, L.
    Oturai, A.
    Sorensen, P.
    Potts, J.
    Hotermans, C.
    Plavina, T.
    Paes, D.
    Subramanyam, M.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S134 - S135
  • [26] Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis
    Hegen, Harald
    Walde, Janette
    Bsteh, Gabriel
    Auer, Michael
    Wurth, Sebastian
    Zinganell, Anne
    Di Pauli, Franziska
    Deisenhammer, Florian
    Berger, Thomas
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [27] Evaluating results of blood serum anti-JCV antibodies of natalizumab treated multiple sclerosis patients
    Kalamatas, T.
    Protopapas, N.
    Lafionati, A.
    Nella, A.
    Graigos, A.
    Karageorgiou, K.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 458 - 458
  • [28] The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings
    Kolcava, Jan
    Hulova, Monika
    Benesova, Yvonne
    Bednarik, Josef
    Stourac, Pavel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 187 - 191
  • [29] Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study
    Hegen, Harald
    Auer, Michael
    Bsteh, Gabriel
    Di Pauli, Franziska
    Plavina, Tatiana
    Walde, Janette
    Deisenhammer, Florian
    Berger, Thomas
    PLOS ONE, 2017, 12 (03):
  • [30] Anti-JCV antibody prevalence in a German MS cohort
    Warnke, C.
    Dehmel, T.
    Posevitz-Fejfar, A.
    Chan, A.
    Berthele, A.
    Schmidt, S.
    Haas, J.
    Kronsbein, H.
    Tackenberg, B.
    Maeurer, M.
    Gerbershagen, K.
    Limmroth, V.
    Adams, O.
    Hartung, H.
    Gold, R.
    Hemmer, B.
    Wiendl, H.
    Kieseier, B.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S223 - S224
12345